Related references
Note: Only part of the references are listed.CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment
Jiachen Wen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
Pyrazolo[3,4-d]pyrimidine scaffold: A review on synthetic approaches and EGFR and VEGFR inhibitory activities
Asmaa E. Kassab
ARCHIV DER PHARMAZIE (2023)
DruMAP: A Novel Drug Metabolism and Pharmacokinetics Analysis Platform
Hitoshi Kawashima et al.
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Small Molecule Kinase Inhibitor Drugs (1995-2021): Medical Indication, Pharmacology, and Synthesis
Cecilia C. Ayala-Aguilera et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Phenotypic drug discovery: recent successes, lessons learned and new directions
Fabien Vincent et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Targeting tumor cells with pyrazolo[3,4-d] pyrimidine scaffold: A literature review on synthetic approaches, structure activity relationship, structural and target-based mechanisms
Mohamed A. Abdelgawad et al.
ARABIAN JOURNAL OF CHEMISTRY (2022)
Improving target assessment in biomedical research: the GOT-IT recommendations
Christoph H. Emmerich et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
A Review of Newly Diagnosed Glioblastoma
Bryan Oronsky et al.
FRONTIERS IN ONCOLOGY (2021)
A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability
Carolin Temps et al.
CANCER RESEARCH (2021)
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance
Wei Wu et al.
PHARMACOLOGICAL RESEARCH (2021)
Pyrazolopyrimide library screening in glioma cells discovers highly potent antiproliferative leads that target the PI3K/mTOR pathway
Teresa Valero et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor
Frederick W. Goldberg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
High-Content Phenotypic Profiling in Esophageal Adenocarcinoma Identifies Selectively Active Pharmacological Classes of Drugs for Repurposing and Chemical Starting Points for Novel Drug Discovery
Rebecca E. Hughes et al.
SLAS DISCOVERY (2020)
To Kill a Microglia: A Case for CSF1R Inhibitors
Kim N. Green et al.
TRENDS IN IMMUNOLOGY (2020)
CSF1R signaling is a regulator of pathogenesis in progressive MS
Nellwyn Hagan et al.
CELL DEATH & DISEASE (2020)
Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-d]pyrimidine scaffold
Daniel J. Baillache et al.
RSC MEDICINAL CHEMISTRY (2020)
Synthesis and Characterization of a Click-Assembled 18-Atom Macrocycle That Displays Selective AXL Kinase Inhibitory Activity
Olga Cruz-Lopez et al.
ACS OMEGA (2019)
Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors
Mohammed El-Gamal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Development of Potent Inhibitors of Receptor Tyrosine Kinases by Ligand-Based Drug Design and Target-Biased Phenotypic Screening
Samuel H. Myers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium-Functionalized Microdevices
Catherine Adam et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
Lowering Lipophilicity by Adding Carbon: One-Carbon Bridges of Morpholines and Piperazines
Sebastien L. Degorce et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Coral: Clear and Customizable Visualization of Human Kinome Data
Kathleen S. Metz et al.
CELL SYSTEMS (2018)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Synthesis and structure-activity relationship study of pyrazolo[3,4-d]pyrimidines as tyrosine kinase RET inhibitors
Chengyan Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Discovery of pyrazolopyrimidine derivatives as novel inhibitors of ataxia telangiectasia and rad3 related protein (ATR)
Sreekanth A. Ramachandran et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski et al.
NEURO-ONCOLOGY (2016)
Next-generation phenotypic screening
Scott J. Warchal et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase
Craig Fraser et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer
Timothy P. Heffron
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes
Mark-Anthony Bray et al.
NATURE PROTOCOLS (2016)
Origin of the U87MG glioma cell line: Good news and bad news
Marie Allen et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
eCF309: a potent, selective and cell-permeable mTOR inhibitor
Craig Fraser et al.
MEDCHEMCOMM (2016)
UNC2025, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor
Weihe Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Macrophage colony-stimulating factor and cancer: a review
S. Chockalingam et al.
TUMOR BIOLOGY (2014)
Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-κB signaling
R. Park et al.
CELL DEATH & DISEASE (2014)
Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
D. C. Swinney
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Phenotypic screens as a renewed approach for drug discovery
Wei Zheng et al.
DRUG DISCOVERY TODAY (2013)
UNC1062, a new and potent Mer inhibitor
Jing Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Multiplex Cytological Profiling Assay to Measure Diverse Cellular States
Sigrun M. Gustafsdottir et al.
PLOS ONE (2013)
Preparation of 3-Substituted-1-Isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amines as RET Kinase Inhibitors
Peter Diner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia
Jing Liu et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
Steven M. Pollard et al.
CELL STEM CELL (2009)
Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases
Beth Apsel et al.
NATURE CHEMICAL BIOLOGY (2008)
Share Paper
